These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11370644)

  • 1. Comment on Valenciano et al's "Unsafe injecting practices among attendees of syringe exchange programmes in France".
    Des Jarlais DC
    Addiction; 2001 May; 96(5):777-8. PubMed ID: 11370644
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 3. Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.
    Sugarman J; Stalter R; Bokoch K; Liu TY; Donnell D
    IRB; 2015; 37(1):17-9. PubMed ID: 26247080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 5. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.
    Bruce RD; Dvoryak S; Sylla L; Altice FL
    Int J Drug Policy; 2007 Aug; 18(4):326-8. PubMed ID: 17689382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
    Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
    Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
    J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe exchange proposal.
    Jacobs RE
    N J Med; 2002 Dec; 99(12):33-4. PubMed ID: 12510571
    [No Abstract]   [Full Text] [Related]  

  • 11. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program.
    Shotsky WJ; Cooper JG; Klein SJ
    Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.
    Milloy MJ; Wood E
    Addiction; 2009 Apr; 104(4):620-1. PubMed ID: 19335659
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
    Mammen K; Bell J
    Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringe exchange.
    Jacobs R; Toynton P
    N J Med; 2003 Sep; 100(9 Suppl):55-9; quiz 79-80. PubMed ID: 14556605
    [No Abstract]   [Full Text] [Related]  

  • 15. Needle exchange programs and drug use.
    Gutowski WD
    CMAJ; 1998 Jan; 158(2):170-1. PubMed ID: 9469136
    [No Abstract]   [Full Text] [Related]  

  • 16. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City.
    Galea S; Worthington N; Piper TM; Nandi VV; Curtis M; Rosenthal DM
    Addict Behav; 2006 May; 31(5):907-12. PubMed ID: 16139434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHSS approves state's first syringe exchange programs.
    Jacobs FM
    N J Nurse; 2007; 37(5):12. PubMed ID: 18019366
    [No Abstract]   [Full Text] [Related]  

  • 19. Syringe exchange programs.
    AIDS Patient Care STDS; 1998 Dec; 12(12):893. PubMed ID: 11362057
    [No Abstract]   [Full Text] [Related]  

  • 20. Study identifies traits of effective needle exchange programs.
    AIDS Policy Law; 2004 Dec; 20(1):1, 4. PubMed ID: 15651103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.